Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Too many samples

    So I've been given transcriptome data for ... quite a lot of samples (>500). It's all from various tumours from one specific tumour type. There's a clinical grading for how serious each tumour is.

    My concern is that, given it's cancer, within the groups formed by the clinical grading, there's probably a fair amount of variability. Which means that if we attempt differential expression analysis, then it's possible (likely?) that the differences within the clinical grading could obscure the differences between the groups.

    If one is looking for the best way to identify several different sets of genes for each clinical grading group, so as to be able to identify them, what's the best approach? My initial thoughts involve some form of clustering to identify sub groups within each clinical grading, but without knowing which genes to look at beforehand, that's going to end up with me attempting to cluster 20,000 odd genes, which, if I recall correctly, would be prohibitive, time-wise.

    What's the best approach for this sort of thing?

Latest Articles

Collapse

  • seqadmin
    Current Approaches to Protein Sequencing
    by seqadmin


    Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
    04-04-2024, 04:25 PM
  • seqadmin
    Strategies for Sequencing Challenging Samples
    by seqadmin


    Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
    03-22-2024, 06:39 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 04-11-2024, 12:08 PM
0 responses
25 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 10:19 PM
0 responses
27 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 09:21 AM
0 responses
24 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-04-2024, 09:00 AM
0 responses
52 views
0 likes
Last Post seqadmin  
Working...
X